Dissociation constants and relative efficacies of agonists acting on alpha adrenergic receptors in rabbit aorta

JC Besse and RF Furchgott

The dissociation constants (KA values) of l-norepinephrine (l-NE) and seven other agonists acting on alpha adrenergic receptors in rabbit aorta strips were determined by analysis of concentration-response data before and after fractional inactivation of receptors with Dibenamine. In experiments to determine KA values, propranolol was added to block activation of beta receptors and cocaine to block the neuronal uptake mechanism. The KA of l-NE and the KA of a second agonist, when determined on paired strips from the same aorta, were used to calculate the relative affinity and the relative efficacy (er) of the second agonist as compared to l-NE. The validity of the method used for determining KA and er values was supported by the following findings. 1) The dissociation constant (KB) of the competitive antagonist, phentolamine, determined with each of the agonists, was the same as that determined with l-NE. 2) The KA determined for l-NE was independent of the fraction of active receptors remaining (q) after pretreatment with different concentrations of Dibenamine. 3) The KB of phentolamine determined with l-NE as the agonist was the same before and after fractional inactivation of receptors. 4) After inactivation in paired strips by equal exposures to Dibenamine, the q value determined with each agonist was the same as that determined with l-NE. The mean KA value for l-NE was 3.39 +/- 0.15 X 10(-7) M. The mean relative affinities of the agonists for the alpha receptor were: l-NE, 1;L-EPINEPHRINE, 1.25; L-PHENYLEPHRINE, 0.200; L-norphenylephrine, 0.217; epinine, 0.136; dopamine, 0.0055; l-alpha-methylnorepinephrine, 0.095; dl-alpha-ethylnorepinephrine, 0.0048. The mean er of each agonist was not significantly different from that of l-NE, except for l- norphenylephrine with an e of 0.71, and dl-alpha-ethylnorepinephrine with an er of 0.41. The results are discussed from the standpoint of structure-activity relationships.

Volume 197, Issue 1, pp. 66-78, 04/01/1976
Copyright © 1976 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				Z.-C. Fan, J. L Sartin, and Y.-X. Tao Molecular cloning and pharmacological characterization of porcine melanocortin-3 receptor J. Endocrinol., January 1, 2008; 196(1): 139 - 148. [Abstract] [Full Text] [PDF]

				R. A. M. B. Borgheresi, J. M. G. Leroy, A. Yogi, R. A. DosSantos, M. C. Breno, and R. C. Tostes Pharmacologic and Molecular Characterization of the Vascular ETA Receptor in the Venomous Snake Bothrops jararaca. Experimental Biology and Medicine, June 1, 2006; 231(6): 729 - 735. [Abstract] [Full Text] [PDF]

				M. Floreani, G. Froldi, L. Quintieri, K. Varani, P. A. Borea, M. T. Dorigo, and P. Dorigo In Vitro Evidence That Carteolol Is a Nonconventional Partial Agonist of Guinea Pig Cardiac {beta}1-Adrenoceptors: A Comparison with Xamoterol J. Pharmacol. Exp. Ther., December 1, 2005; 315(3): 1386 - 1395. [Abstract] [Full Text] [PDF]

				M. A. de Paula Brotto Temporal Effects of Stress by Immobilization and Sensitivity of the Isolated Rat Pacemaker to Isoproterenol: Roles of Corticosterone, Neuronal Uptake, and {beta}-Adrenergic Homogeneity J. Pharmacol. Exp. Ther., September 1, 2003; 306(3): 1152 - 1158. [Abstract] [Full Text] [PDF]

				D. Chalothorn, D. F. McCune, S. E. Edelmann, K. Tobita, B. B. Keller, R. D. Lasley, D. M. Perez, A. Tanoue, G. Tsujimoto, G. R. Post, et al. Differential Cardiovascular Regulatory Activities of the {alpha}1B- and {alpha}1D-Adrenoceptor Subtypes J. Pharmacol. Exp. Ther., June 1, 2003; 305(3): 1045 - 1053. [Abstract] [Full Text] [PDF]

				S. L. Borgland, M. Connor, P. B. Osborne, J. B. Furness, and M. J. Christie Opioid Agonists Have Different Efficacy Profiles for G Protein Activation, Rapid Desensitization, and Endocytosis of Mu-opioid Receptors J. Biol. Chem., May 23, 2003; 278(21): 18776 - 18784. [Abstract] [Full Text] [PDF]

				Y. P.R Jarajapu, J. C McGrath, C. Hillier, and A. MacDonald The {alpha}1-adrenoceptor profile in human skeletal muscle resistance arteries in critical limb ischaemia Cardiovasc Res, February 1, 2003; 57(2): 554 - 562. [Abstract] [Full Text] [PDF]

				D. S. Sangha, S. Han, and R. E. Purdy Simulated microgravity upregulates an endothelial vasoconstrictor prostaglandin J Appl Physiol, August 1, 2001; 91(2): 789 - 796. [Abstract] [Full Text] [PDF]

				D. S. Sangha, N. D. Vaziri, Y. Ding, and R. E. Purdy Vascular hyporesponsiveness in simulated microgravity: role of nitric oxide-dependent mechanisms J Appl Physiol, February 1, 2000; 88(2): 507 - 517. [Abstract] [Full Text] [PDF]

				R. E. Purdy, S. P. Duckles, D. N. Krause, K. M. Rubera, and D. Sara Effect of simulated microgravity on vascular contractility J Appl Physiol, October 1, 1998; 85(4): 1307 - 1315. [Abstract] [Full Text] [PDF]

				J. W. Hubbard, S. T. Nordstrom, C. P. Smith, K. M. Brooks, L. Laws-Ricker, L. Zhou, and H. M. Vargas alpha -Adrenergic Activity and Cardiovascular Effects of Besipirdine HCl (HP 749) and Metabolite P7480 in Vitro and in the Conscious Rat and Dog J. Pharmacol. Exp. Ther., April 1, 1997; 281(1): 337 - 346. [Abstract] [Full Text]

				J. Bevan, M. Oriowo, and R. Bevan Physiological variation in alpha-adrenoceptor-mediated arterial sensitivity: relation to agonist affinity Science, October 10, 1986; 234(4773): 196 - 197. [Abstract] [PDF]